Evidence map›Paper›PMID 36439123›Full record

ArticleFrontiers in immunology2022

Identification and validation of a signature based on macrophage cell marker genes to predict recurrent miscarriage by integrated analysis of single-cell and bulk RNA-sequencing.

Peiru Wei, Mingyou Dong, Yin Bi, Saiqiong Chen, Weiyu Huang, Ting Li, Bo Liu, Xiaoqian Fu, Yihua Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. SAV1 in Cooperation With FKBP52 Participates in Implantation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. NSUN2-Mediated mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Immune activation induced by FOLR2Frontiers in immunology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Peiru WeiGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Mingyou DongGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yin BiGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Saiqiong ChenGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Weiyu HuangGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Ting LiGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Bo LiuGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiaoqian FuGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yihua YangGuangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
First Affiliated Hospital of GuangXi Medical University · CNTumor Hospital of Guangxi Medical University · CNFourth Affiliated Hospital of Guangxi Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent miscarriage (RM) is a chronic, heterogeneous autoimmune disease that has serious social and personal consequences. No valid and reliable diagnostic markers or therapeutic targets for RM have been identified. Macrophages impact the innate immune system and can be used as diagnostic and prognostic markers for many diseases. We first collected 16 decidua and villi tissue samples from 5 normal patients and 3 RM patients for single-cell RNA sequencing data analysis and identified 1293 macrophage marker genes. We then screened a recurrent miscarriage cohort (GSE165004) for 186 macrophage-associated marker genes that were significantly differentially expressed between RM patients and the normal pregnancy endometrial tissues, and performed a functional enrichment analysis of differentially expressed genes. We then identified seven core genes (ACTR2, CD2AP, MBNL2, NCSTN, PUM1, RPN2, and TBC1D12) from the above differentially expressed gene group that are closely related to RM using the LASSO, Random Forest and SVM-RFE algorithms. We also used GSE26787 and our own collection of clinical specimens to further evaluate the diagnostic value of the target genes. A nomogram was constructed of the expression levels of these seven target genes to predict RM, and the ROC and calibration curves showed that our nomogram had a high diagnostic value for RM. These results suggest that ACTR2 and NCSTN may be potential targets for preventative RM treatments.

Indexed as

Abortion, HabitualHexosyltransferasesBiomarkersFemaleHumansMacrophagesPregnancyProteasome Endopeptidase ComplexRNARNA-Binding ProteinsSequence Analysis, RNABiomarkersHexosyltransferasesProteasome Endopeptidase ComplexPUM1 protein, humanRNARNA-Binding ProteinsRPN2 protein, humanbulk RNA-sequencingmacrophagematernal fetal interfacerecurrent miscarriagesingle-cell RNA-sequencing

Identifiers

PMID36439123
PMCPMC9692009
OpenAlexW4308936190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.